Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The use of TNF-alpha blockers in Cogan's syndrome.

× No keyword cloud information.

1 in total

1. A novel therapeutic option in Cogan diseases? TNF-alpha blockers.

Authors: M Fricker; A Baumann; F Wermelinger; P M Villiger; A Helbling
Journal: Rheumatol Int Date: 2007-03 Impact factor: 2.631

1 in total

6 in total

Review 1. Cogan's syndrome--clinical guidelines and novel therapeutic approaches.

Authors: Oshrat E Tayer-Shifman; Ophir Ilan; Hodaya Tovi; Yuval Tal
Journal: Clin Rev Allergy Immunol Date: 2014-08 Impact factor: 8.667

Review 2. Ocular, Auricular, and Oral Manifestations of Inflammatory Bowel Disease.

Authors: Sean Fine; Judy Nee; Pranjal Thakuria; Brian Duff; Francis A Farraye; Samir A Shah
Journal: Dig Dis Sci Date: 2017-10-24 Impact factor: 3.199

3. Infliximab has no apparent effect in the inner ear hearing function of patients with rheumatoid arthritis and ankylosing spondylitis.

Authors: H Toktas; E Okur; U Dundar; A Dikici; O K Kahveci
Journal: Clin Rheumatol Date: 2014-04-27 Impact factor: 2.980

4. Interstitial Keratitis, Vertigo, and Vasculitis: Typical Cogan's Syndrome.

Authors: Ahad Azami; Nasrollah Maleki; Mohammadreza Kalantar Hormozi; Zahra Tavosi
Journal: Case Rep Med Date: 2014-03-04

Review 5. Optimal management of Cogan's syndrome: a multidisciplinary approach.

Authors: Vittorio D'Aguanno; Massimo Ralli; Marco de Vincentiis; Antonio Greco
Journal: J Multidiscip Healthc Date: 2017-12-22

Review 6. Autoimmune Inner Ear Disease: Immune Biomarkers, Audiovestibular Aspects, and Therapeutic Modalities of Cogan's Syndrome.

Authors: Oded Shamriz; Yuval Tal; Menachem Gross
Journal: J Immunol Res Date: 2018-04-23 Impact factor: 4.818

6 in total